Free Trial

IceCure Medical Q3 2023 Earnings Report

IceCure Medical logo
$1.08 -0.04 (-3.57%)
(As of 12:23 PM ET)

IceCure Medical EPS Results

Actual EPS
-$0.09
Consensus EPS
-$0.09
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

IceCure Medical Revenue Results

Actual Revenue
$0.33 million
Expected Revenue
$0.95 million
Beat/Miss
Missed by -$620.00 thousand
YoY Revenue Growth
N/A

IceCure Medical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Trading 5-7 Stocks to Profit $1,300 a Day? (Ad)

If you want a straightforward, faster, and potentially more reliable way to trade… Learn this strategy by watching this brand new video presentation

Click here to learn the 5-Stock Formula that could potentially boost your profit potential.

IceCure Medical Earnings Headlines

Icecure Medical: Strong Growth and Regulatory Momentum Support Buy Rating
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
IceCure Medical Sees Strong Growth Amid ProSense® Adoption
See More IceCure Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IceCure Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IceCure Medical and other key companies, straight to your email.

About IceCure Medical

IceCure Medical (NASDAQ:ICCM), a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

View IceCure Medical Profile

More Earnings Resources from MarketBeat